{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T05:27:39Z","timestamp":1704346059135},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,25]],"date-time":"2013-12-25T00:00:00Z","timestamp":1387929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00104-013-2563-3","type":"journal-article","created":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T10:48:45Z","timestamp":1387795725000},"page":"31-36","source":"Crossref","is-referenced-by-count":1,"title":["CT-morphologische Evaluation neoadjuvanter Chemotherapie"],"prefix":"10.1007","volume":"85","author":[{"given":"G.","family":"Folprecht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.-T.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,25]]},"reference":[{"key":"2563_CR1","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/cncr.24912","volume":"116","author":"Auer","year":"2010","unstructured":"Auer RC, White RR, Kemeny NE et al (2010) Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy. Cancer 116:1502\u20131509","journal-title":"Cancer"},{"key":"2563_CR2","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1200\/JCO.2006.05.8727","volume":"24","author":"Benoist","year":"2006","unstructured":"Benoist S, Brouquet A, Penna C et al (2006) Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24:3939\u20133945","journal-title":"J Clin Oncol"},{"key":"2563_CR3","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1001\/jama.2009.1755","volume":"302","author":"Chun","year":"2009","unstructured":"Chun YS, Vauthey JN, Boonsirikamchai P et al (2009) Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA 302:2338\u20132344","journal-title":"JAMA"},{"key":"2563_CR4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247","journal-title":"Eur J Cancer"},{"key":"2563_CR5","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/annonc\/mdi246","volume":"16","author":"Folprecht","year":"2005","unstructured":"Folprecht G, Grothey A, Alberts S et al (2005) Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 16:1311\u20131319","journal-title":"Ann Oncol"},{"key":"2563_CR6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1470-2045(09)70330-4","volume":"11","author":"Folprecht","year":"2010","unstructured":"Folprecht G, Gruenberger T, Bechstein WO et al (2010) Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol 11:38\u201347","journal-title":"Lancet Oncol"},{"key":"2563_CR7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.critrevonc.2013.01.004","volume":"87","author":"Hartmann","year":"2013","unstructured":"Hartmann M, Mayer-Nicolai C, Pfaff O (2013) Approval probabilities and regulatory review patterns for anticancer drugs in the European Union. Crit Rev Oncol Hematol 87:112\u2013121","journal-title":"Crit Rev Oncol Hematol"},{"key":"2563_CR8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1470-2045(06)70800-2","volume":"7","author":"Johnson","year":"2006","unstructured":"Johnson KR, Ringland C, Stokes BJ et al (2006) Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysis. Lancet Oncol 7:741\u2013746","journal-title":"Lancet Oncol"},{"key":"2563_CR9","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1200\/JCO.2008.20.1301","volume":"27","author":"Kemeny","year":"2009","unstructured":"Kemeny NE, Melendez FDH, Capanu M et al (2009) Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol 27:3465\u20133471","journal-title":"J Clin Oncol"},{"key":"2563_CR10","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ejca.2012.08.022","volume":"49","author":"Kim","year":"2013","unstructured":"Kim BK, Kim KA, Park JY et al (2013) Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation. Eur J Cancer 49:826\u2013834","journal-title":"Eur J Cancer"},{"key":"2563_CR11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207\u2013214","journal-title":"Cancer"},{"key":"2563_CR12","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1200\/jco.2011.29.15_suppl.3520","volume":"Oncol","author":"Moulton","year":"2011","unstructured":"Moulton C, Levine MN, Law C et al (2011) An Ontario Clinical Oncology Group (OCOG) randomized controlled trial (RCT) assessing FDG PET\/CT in resectable liver colorectal adenocarcinoma metastases (CAM). J Clin Oncol (Meeting Abstracts) 29:3520","journal-title":"J Clin"},{"key":"2563_CR13","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1148\/radiol.10100729","volume":"257","author":"Niekel","year":"2010","unstructured":"Niekel MC, Bipat S, Stoker J (2010) Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and\/or FDG PET\/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 257:674\u2013684","journal-title":"Radiology"},{"key":"2563_CR14","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/SLA.0b013e31821110c9","volume":"253","author":"Patel","year":"2011","unstructured":"Patel S, McCall M, Ohinmaa A et al (2011) Positron emission tomography\/computed tomographic scans compared to computed tomographic scans for detecting colorectal liver metastases: a systematic review. Ann Surg 253:666\u2013671","journal-title":"Ann Surg"},{"key":"2563_CR15","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1200\/JCO.2012.42.8532","volume":"31","author":"Piessevaux","year":"2013","unstructured":"Piessevaux H, Buyse M, Schlichting M et al (2013) Use of early tumor shrinkage to predict long-term outcome in metastatic colorectal cancer treated with cetuximab. J Clin Oncol 31:3764\u20133775","journal-title":"J Clin Oncol"},{"key":"2563_CR16","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2967\/jnumed.109.063040","volume":"50","author":"Ruers","year":"2009","unstructured":"Ruers TJ, Wiering B, van der Siip Jr et al (2009) Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study. J Nucl Med 50:1036\u20131041","journal-title":"J Nucl Med"},{"key":"2563_CR17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/annonc\/mdp523","volume":"21","author":"Saad","year":"2010","unstructured":"Saad ED, Katz A, Hoff PM, Buyse M (2010) Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literature. Ann Oncol 21:7\u201312","journal-title":"Ann Oncol"},{"key":"2563_CR18","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1200\/JCO.2012.45.2854","volume":"30","author":"Shindoh","year":"2012","unstructured":"Shindoh J, Loyer EM, Kopetz S et al (2012) Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol 30:4566\u20134572","journal-title":"J Clin Oncol"},{"key":"2563_CR19","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1200\/jco.2013.31.15_suppl.3520","volume":"Oncol","author":"Sommeijer","year":"2013","unstructured":"Sommeijer DW, Shi Q, Meyers JP et al (2013) Prognostic value of early objective tumor response (EOTR) to first-line systemic therapy in metastatic colorectal cancer (mCRC): Individual patient data (IPD) meta-analysis of randomized trials from the ARCAD database. J Clin Oncol (Meeting Abstracts) 31:3520","journal-title":"J Clin"},{"key":"2563_CR20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejso.2011.10.013","volume":"38","author":"Spelt","year":"2012","unstructured":"Spelt L, Andersson B, Nilsson J, Andersson R (2012) Prognostic models for outcome following liver resection for colorectal cancer metastases: a systematic review. Eur J Surg Oncol 38:16\u201324","journal-title":"Eur J Surg Oncol"},{"key":"2563_CR21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-013-2563-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00104-013-2563-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-013-2563-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T20:09:22Z","timestamp":1597262962000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00104-013-2563-3"}},"subtitle":["Effektivit\u00e4t der Therapie bei kolorektalen Lebermetastasen"],"short-title":[],"issued":{"date-parts":[[2013,12,25]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["2563"],"URL":"https:\/\/doi.org\/10.1007\/s00104-013-2563-3","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"value":"0009-4722","type":"print"},{"value":"1433-0385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,25]]}}}